{"id":"https://openalex.org/W3098149335","doi":"https://doi.org/10.1158/1078-0432.ccr-20-3139","title":"Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo","display_name":"Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo","publication_year":2020,"publication_date":"2020-11-18","ids":{"openalex":"https://openalex.org/W3098149335","doi":"https://doi.org/10.1158/1078-0432.ccr-20-3139","mag":"3098149335","pmid":"https://pubmed.ncbi.nlm.nih.gov/33208342","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8287597"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-20-3139","doi":"https://doi.org/10.1158/1078-0432.ccr-20-3139","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-20-3139","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/27/4/1139/2068364/1139.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/clincancerres/article-pdf/27/4/1139/2068364/1139.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038581738","display_name":"Eleni Anastasiadou","orcid":"https://orcid.org/0000-0003-0212-6734","observed_orcids":["https://orcid.org/0000-0003-0212-6734"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT","US"],"is_corresponding":false,"raw_author_name":"Eleni Anastasiadou","raw_affiliation_strings":["1HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts","2Department of Experimental Medicine, Sapienza University of Rome, Italy"],"raw_orcid":"https://orcid.org/0000-0003-0212-6734","affiliations":[{"raw_affiliation_string":"1HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]},{"raw_affiliation_string":"2Department of Experimental Medicine, Sapienza University of Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047894954","display_name":"Anita G. Seto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117397","display_name":"Miragen Therapeutics (United States)","ror":"https://ror.org/02dk28s26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117397"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anita G. Seto","raw_affiliation_strings":["3miRagen Therapeutics, Inc, Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3miRagen Therapeutics, Inc, Boulder, Colorado","institution_ids":["https://openalex.org/I4210117397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039807062","display_name":"Xuan Beatty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117397","display_name":"Miragen Therapeutics (United States)","ror":"https://ror.org/02dk28s26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117397"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xuan Beatty","raw_affiliation_strings":["3miRagen Therapeutics, Inc, Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3miRagen Therapeutics, Inc, Boulder, Colorado","institution_ids":["https://openalex.org/I4210117397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086384742","display_name":"Melanie Hermreck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117397","display_name":"Miragen Therapeutics (United States)","ror":"https://ror.org/02dk28s26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117397"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melanie Hermreck","raw_affiliation_strings":["3miRagen Therapeutics, Inc, Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3miRagen Therapeutics, Inc, Boulder, Colorado","institution_ids":["https://openalex.org/I4210117397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042296387","display_name":"Maud-Emmanuelle Gilles","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maud-Emmanuelle Gilles","raw_affiliation_strings":["1HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102834605","display_name":"Dina Stroopinsky","orcid":"https://orcid.org/0000-0002-9749-2704","observed_orcids":["https://orcid.org/0000-0002-9749-2704"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dina Stroopinsky","raw_affiliation_strings":["4Department of Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074536375","display_name":"Lauren C. Pinter\u2010Brown","orcid":"https://orcid.org/0000-0002-0919-4951","observed_orcids":["https://orcid.org/0000-0002-0919-4951"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren C. Pinter-Brown","raw_affiliation_strings":["5Department of Internal Medicine, Division of Hematology/Oncology, University of California, Irvine, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Internal Medicine, Division of Hematology/Oncology, University of California, Irvine, California","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043317954","display_name":"Linda A. Pestano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117397","display_name":"Miragen Therapeutics (United States)","ror":"https://ror.org/02dk28s26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117397"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda Pestano","raw_affiliation_strings":["3miRagen Therapeutics, Inc, Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3miRagen Therapeutics, Inc, Boulder, Colorado","institution_ids":["https://openalex.org/I4210117397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075605378","display_name":"Cinzia Marchese","orcid":"https://orcid.org/0000-0002-9280-8917","observed_orcids":["https://orcid.org/0000-0002-9280-8917"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Cinzia Marchese","raw_affiliation_strings":["2Department of Experimental Medicine, Sapienza University of Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Experimental Medicine, Sapienza University of Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052641327","display_name":"David Avigan","orcid":"https://orcid.org/0000-0003-4624-6017","observed_orcids":["https://orcid.org/0000-0003-4624-6017"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Avigan","raw_affiliation_strings":["4Department of Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028660383","display_name":"Pankaj Trivedi","orcid":"https://orcid.org/0000-0001-9574-6304","observed_orcids":["https://orcid.org/0000-0001-9574-6304"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Pankaj Trivedi","raw_affiliation_strings":["2Department of Experimental Medicine, Sapienza University of Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Experimental Medicine, Sapienza University of Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024521380","display_name":"Diana M. Escolar","orcid":"https://orcid.org/0000-0003-2455-3630","observed_orcids":["https://orcid.org/0000-0003-2455-3630"]},"institutions":[{"id":"https://openalex.org/I4210117397","display_name":"Miragen Therapeutics (United States)","ror":"https://ror.org/02dk28s26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117397"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diana M. Escolar","raw_affiliation_strings":["3miRagen Therapeutics, Inc, Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3miRagen Therapeutics, Inc, Boulder, Colorado","institution_ids":["https://openalex.org/I4210117397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008348483","display_name":"Aimee L. Jackson","orcid":"https://orcid.org/0000-0002-3786-7391","observed_orcids":["https://orcid.org/0000-0002-3786-7391"]},"institutions":[{"id":"https://openalex.org/I4210117397","display_name":"Miragen Therapeutics (United States)","ror":"https://ror.org/02dk28s26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117397"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aimee L. Jackson","raw_affiliation_strings":["3miRagen Therapeutics, Inc, Boulder, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3miRagen Therapeutics, Inc, Boulder, Colorado","institution_ids":["https://openalex.org/I4210117397"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013989133","display_name":"Frank John Slack","orcid":"https://orcid.org/0000-0001-8263-0409","observed_orcids":["https://orcid.org/0000-0001-8263-0409"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Frank J. Slack","raw_affiliation_strings":["1HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5013989133"],"corresponding_institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"],"apc_list":null,"apc_paid":null,"fwci":5.8124,"has_fulltext":true,"cited_by_count":157,"citation_normalized_percentile":{"value":0.98361957,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"27","issue":"4","first_page":"1139","last_page":"1149"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.013100000098347664,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mir-155","display_name":"miR-155","score":0.9269999861717224},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.8500000238418579},{"id":"https://openalex.org/keywords/activated-b-cell-subtype","display_name":"activated B-cell subtype","score":0.9309999942779541},{"id":"https://openalex.org/keywords/mirna-inhibitors","display_name":"miRNA inhibitors","score":0.6759999990463257},{"id":"https://openalex.org/keywords/oligonucleotide-therapeutics","display_name":"oligonucleotide therapeutics","score":0.8539999723434448},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6779999732971191},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.7360000014305115},{"id":"https://openalex.org/keywords/mouse-xenograft-model","display_name":"xenograft mouse model","score":0.828000009059906},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.6895254850387573},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6855641007423401},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6844282150268555},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5926728248596191},{"id":"https://openalex.org/C96926380","wikidata":"https://www.wikidata.org/wiki/Q1737968","display_name":"Germinal center","level":4,"score":0.48712942004203796},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4848681390285492},{"id":"https://openalex.org/C2781214270","wikidata":"https://www.wikidata.org/wiki/Q4692282","display_name":"Aggressive lymphoma","level":4,"score":0.4393364489078522},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4207778573036194},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3911701738834381},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.362749844789505},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2736191153526306},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.1147882342338562},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.08647075295448303},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D035683","descriptor_name":"MicroRNAs","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D035683","descriptor_name":"MicroRNAs","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1078-0432.ccr-20-3139","doi":"https://doi.org/10.1158/1078-0432.ccr-20-3139","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-20-3139","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/27/4/1139/2068364/1139.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:33208342","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33208342","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8287597","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8287597","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"},{"id":"pmh:oai:iris.uniroma1.it:11573/1462698","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11573/1462698","pdf_url":null,"source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.ccr-20-3139","doi":"https://doi.org/10.1158/1078-0432.ccr-20-3139","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-20-3139","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/27/4/1139/2068364/1139.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000892963","display_name":"Precision microRNA medicine in cancer","funder_award_id":"R35CA232105","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306536","display_name":"V Foundation for Cancer Research","ror":"https://ror.org/00kbbk236"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3098149335.pdf","grobid_xml":"https://content.openalex.org/works/W3098149335.grobid-xml"},"referenced_works_count":56,"referenced_works":["https://openalex.org/W1168460382","https://openalex.org/W1223416685","https://openalex.org/W1566055428","https://openalex.org/W1895425086","https://openalex.org/W1941864838","https://openalex.org/W1967007963","https://openalex.org/W1967705046","https://openalex.org/W1969998568","https://openalex.org/W1979962936","https://openalex.org/W1984067003","https://openalex.org/W1997393575","https://openalex.org/W2006070956","https://openalex.org/W2015844263","https://openalex.org/W2025449301","https://openalex.org/W2034835460","https://openalex.org/W2038149830","https://openalex.org/W2042968293","https://openalex.org/W2048158327","https://openalex.org/W2056868280","https://openalex.org/W2062457956","https://openalex.org/W2066024172","https://openalex.org/W2072351874","https://openalex.org/W2072646319","https://openalex.org/W2078224598","https://openalex.org/W2082762381","https://openalex.org/W2092308103","https://openalex.org/W2102824849","https://openalex.org/W2125071715","https://openalex.org/W2128733367","https://openalex.org/W2131940231","https://openalex.org/W2136060045","https://openalex.org/W2139836848","https://openalex.org/W2147246240","https://openalex.org/W2153667947","https://openalex.org/W2155518647","https://openalex.org/W2165195065","https://openalex.org/W2168494970","https://openalex.org/W2392273486","https://openalex.org/W2470708296","https://openalex.org/W2559244103","https://openalex.org/W2559431510","https://openalex.org/W2588025094","https://openalex.org/W2630192492","https://openalex.org/W2768096340","https://openalex.org/W2783418022","https://openalex.org/W2797584152","https://openalex.org/W2801763724","https://openalex.org/W2811453807","https://openalex.org/W2888531381","https://openalex.org/W2896375207","https://openalex.org/W2898045030","https://openalex.org/W2901972747","https://openalex.org/W2914869182","https://openalex.org/W2944684880","https://openalex.org/W4235541467","https://openalex.org/W4238545515"],"related_works":["https://openalex.org/W2888531381","https://openalex.org/W3025545094","https://openalex.org/W2559244103","https://openalex.org/W2413748021","https://openalex.org/W2983138788","https://openalex.org/W2155518647","https://openalex.org/W2622923176","https://openalex.org/W1965835664","https://openalex.org/W4404584817","https://openalex.org/W2259906034"],"abstract_inverted_index":{"PURPOSE:":[0],"miRNA-155":[1],"is":[2,29],"an":[3,41,59],"oncogenic":[4],"miRNA":[5],"highly":[6,103],"expressed":[7],"in":[8,12,65,70,86,120,165,173,217],"B-cell":[9,16,19,24,46],"malignancies,":[10],"particularly":[11],"the":[13,53,79,98,133,193,205,211],"non-germinal":[14],"center":[15],"or":[17],"activated":[18],"subtype":[20],"of":[21,58,62,84,100,118,132,154,171,179,215,222],"diffuse":[22],"large":[23],"lymphoma":[25,223],"(ABC-DLBCL),":[26],"where":[27],"it":[28],"considered":[30],"a":[31,87,146,174],"potential":[32,212],"diagnostic":[33],"and":[34,55,69,82,130,143,162,186,196,219],"prognostic":[35],"biomarker.":[36],"Thus,":[37],"miR-155":[38,189,226],"inhibition":[39],"represents":[40],"important":[42],"therapeutic":[43,80,144,213],"strategy":[44],"for":[45,204],"lymphomas.":[47],"In":[48,75],"this":[49],"study,":[50],"we":[51,77],"tested":[52],"efficacy":[54,81],"pharmacodynamic":[56],"activity":[57],"oligonucleotide":[60],"inhibitor":[61],"miR-155,":[63],"cobomarsen,":[64],"ABC-DLBCL":[66,105,124,166,180,218],"cell":[67,106,160,167],"lines":[68,107],"corresponding":[71],"xenograft":[72,175],"mouse":[73,177],"models.":[74],"addition,":[76],"assessed":[78],"safety":[83,142],"cobomarsen":[85,101,119,155,172,216],"patient":[88,147],"diagnosed":[89],"with":[90,224],"aggressive":[91],"ABC-DLBCL.":[92],"EXPERIMENTAL":[93],"DESIGN:":[94],"Preclinical":[95],"studies":[96],"included":[97],"delivery":[99],"to":[102,108,126,139],"miR-155-expressing":[104],"assess":[109],"any":[110,201],"phenotypic":[111],"changes,":[112],"as":[113,115],"well":[114],"intravenous":[116],"injections":[117],"NSG":[121,176],"mice":[122],"carrying":[123],"xenografts,":[125],"study":[127],"tumor":[128,182,198],"growth":[129,199],"pharmacodynamics":[131],"compound":[134,194],"over":[135],"time.":[136],"To":[137],"begin":[138],"test":[140],"its":[141],"efficacy,":[145],"was":[148],"recruited":[149],"who":[150],"underwent":[151],"five":[152],"cycles":[153],"treatment.":[156],"RESULTS:":[157],"Cobomarsen":[158],"decreased":[159],"proliferation":[161],"induced":[163],"apoptosis":[164],"lines.":[168],"Intravenous":[169],"administration":[170],"model":[178],"reduced":[181,195],"volume,":[183],"triggered":[184],"apoptosis,":[185],"derepressed":[187],"direct":[188],"target":[190],"genes.":[191],"Finally,":[192],"stabilized":[197],"without":[200],"toxic":[202],"effects":[203],"patient.":[206],"CONCLUSIONS:":[207],"Our":[208],"findings":[209],"support":[210],"application":[214],"other":[220],"types":[221],"elevated":[225],"expression.":[227]},"counts_by_year":[{"year":2026,"cited_by_count":22},{"year":2025,"cited_by_count":31},{"year":2024,"cited_by_count":36},{"year":2023,"cited_by_count":18},{"year":2022,"cited_by_count":28},{"year":2021,"cited_by_count":22}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-11-23T00:00:00"}